Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes

Yang,Zheng; Liu,Yuan; Deng,Wei; Dai,Jia; Li,Fangfang; Yuan,Yuan; Wu,Qingqing; Zhou,Heng; Bian,Zhouyan; Tang,Qizhu

doi:10.3892/mmr.2014.2002

Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes

Authors:
- Zheng Yang
- Yuan Liu
- Wei Deng
- Jia Dai
- Fangfang Li
- Yuan Yuan
- Qingqing Wu
- Heng Zhou
- Zhouyan Bian
- Qizhu Tang
View Affiliations

Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: March 4, 2014 https://doi.org/10.3892/mmr.2014.2002
Pages: 1941-1946

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Apoptosis is closely associated with the occurrence and development of cardiovascular diseases and is considered as one of the crucial pathological processes of cardiomyopathy, sepsis, ischemia/reperfusion injury, myocardial infarction and heart failure. Hesperetin (HES), a flavanone glycoside found in citrus fruit peels, has been known to exhibit several key biological and pharmacological properties. Previous studies have demonstrated the anti-inflammatory, anti-oxidant and anti-tumor functions of HES. However, with regards to the pro- or anti-apoptotic functions of HES, there are several disagreements within the literature. To examine whether HES has protective effects in cardiac apoptosis, the present study examined the role of HES in lipopolysaccharide (LPS)-stimulated H9C2 cardiomyocytes, aiming to clarify the possible mechanisms underlying its effects. In the present study, HES reduced the percentage of viable apoptotic (VA) cells in a flow cytometry analysis. It had an anti-apoptosis function in LPS-stimulated H9C2 cells. To clarify whether HES alleviated LPS-stimulated apoptosis through the mitochondria-dependent intrinsic apoptotic pathway, certain indicators of this pathway were detected, including members of the caspase family. The data revealed that HES attenuated the activation of capase-3 and caspase-9. These results indicated HES has a mitochondria-dependent anti-apoptosis effect in LPS-stimulated H9C2 cells. To explore the possible mechanisms, the protein expression levels of certain markers in the possible signaling pathway were detected, including JNK and Bcl-2 family. As a result, HES downregulated the protein expression of Bax, upregulated the expression of Bcl-2 and attenuated the phosphorylation level of JNK. Therefore, the anti-apoptosis effects of HES were possibly mediated by the JNK/Bax signaling pathway. In conclusion, HES has a mitochondria-dependent anti-apoptosis effect in LPS-induced H9C2 cells via the JNK/Bax signaling pathway.

View Figures

View References

1	Marcus FI, Edson S and Towbin JA: Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol. 61:1945–1948. 2013. View Article : Google Scholar : PubMed/NCBI
2	Sanbe A: Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull. 36:18–22. 2013. View Article : Google Scholar : PubMed/NCBI
3	Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K and Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 29:497–503. 2008. View Article : Google Scholar : PubMed/NCBI
4	Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian H, Huang L and Zhang L: Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension. 60:81–89. 2012. View Article : Google Scholar : PubMed/NCBI
5	Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, Heimesaat MM, Bereswill S, Völker U, Escher F, Riad A, Plendl J, Klingel K, Poller W, Schultheiss HP and Tschöpe C: Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation. 124:2082–2093. 2011. View Article : Google Scholar
6	Consoli C, Gatta L, Iellamo F, Molinari F, Rosano GM and Marlier LN: Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism. Int J Cardiol. 167:2859–2866. 2013. View Article : Google Scholar
7	Loughran JH, Chugh AR, Ismail I and Bolli R: Stem cell therapy: promising treatment in heart failure? Curr Heart Fail Rep. 10:73–80. 2013. View Article : Google Scholar : PubMed/NCBI
8	Carneiro AV: Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction. Rev Port Cardiol. 27:851–856. 2008.(In Portuguese).
9	Tang WH and Huang Y: Cardiotonic modulation in heart failure: insights from traditional Chinese medicine. J Am Coll Cardiol. 62:1073–1074. 2013. View Article : Google Scholar : PubMed/NCBI
10	Beadle R and Williams L: Device therapy in hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther. 8:1767–1775. 2010. View Article : Google Scholar : PubMed/NCBI
11	Del Corsso C and Campos de Carvalho AC: Cell therapy in dilated cardiomyopathy: from animal models to clinical trials. Braz J Med Biol Res. 44:388–393. 2011.PubMed/NCBI
12	Wang J, Zhu H, Yang Z and Liu Z: Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian J Pharmacol. 45:395–398. 2013. View Article : Google Scholar : PubMed/NCBI
13	Deng W, Jiang D, Fang Y, Zhou H, Cheng Z, Lin Y, Zhang R, Zhang J, Pu P, Liu Y, Bian Z and Tang Q: Hesperetin protects against cardiac remodelling induced by pressure overload in mice. J Mol Histol. 44:575–585. 2013. View Article : Google Scholar : PubMed/NCBI
14	Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S and Saxena R: Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascul Pharmacol. 57:201–107. 2012. View Article : Google Scholar : PubMed/NCBI
15	Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R and Jha KA: Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res. 87:65–74. 2013. View Article : Google Scholar : PubMed/NCBI
16	Sambantham S, Radha M, Paramasivam A, Anandan B, Malathi R, Chandra SR and Jayaraman G: Molecular mechanism underlying hesperetin-induced apoptosis by in silico analysis and in prostate cancer PC-3 cells. Asian Pac J Cancer Prev. 14:4347–4352. 2013. View Article : Google Scholar : PubMed/NCBI
17	Morikawa K, Nonaka M, Mochizuki H, Handa K, Hanada H and Hirota K: Naringenin and hesperetin induce growth arrest, apoptosis, and cytoplasmic fat deposit in human preadipocytes. J Agric Food Chem. 56:11030–11037. 2008. View Article : Google Scholar : PubMed/NCBI
18	Yang S, Li R, Qu X, Tang L, Ge G, Fang W, Qiao Z, Ma J, Hou Y and Liu H: Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes. Cell Immunol. 284:182–186. 2013.PubMed/NCBI
19	Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY and Du SX: Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem. 30:123–136. 2012. View Article : Google Scholar : PubMed/NCBI
20	Niu L, Qiao W, Li G, Li Q, Huang Q, Gong J, Zhu W, Li N and Li J: Different alterations in rat intestinal glutamine transport during the progression of CLP- and LPS-induced sepsis. J Surg Res. 169:284–291. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lei L, Wang J, Zhang Z, Zhang H, Chen H and Cai D: Lipopolysaccharide-induced apoptosis in a murine intestinal endocrine cell line by modulation of Bcl-2, Bax and caspase-3. Mol Med Rep. 8:1649–1654. 2013.PubMed/NCBI
22	Sears SF, Woodrow L, Cutitta K, Ford J, Shea JB and Cahill J: A patient’s guide to living confidently with chronic heart failure. Circulation. 127:e525–e528. 2013.
23	Paraskevaidis I, Palios J, Parissis J, Filippatos G and Anastasiou-Nana M: Treating depression in coronary artery disease and chronic heart failure: what’s new in using selective serotonin re-uptake inhibitors? Cardiovasc Hematol Agents Med Chem. 10:109–115. 2012.
24	Fujita T and Ishikawa Y: Apoptosis in heart failure. -The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J. 75:1811–1818. 2011.
25	Peng Z, Wang H, Zhang R, Chen Y, Xue F, Nie H, Chen Y, Wu D, Wang Y, Wang H and Tan Q: Gastrodin ameliorates anxiety-like behaviors and inhibits IL-1beta level and p38 MAPK phosphorylation of hippocampus in the rat model of posttraumatic stress disorder. Physiol Res. 62:537–545. 2013.PubMed/NCBI
26	Yuk TH, Kang JH, Lee SR, Yuk SW, Lee KG, Song BY, Kim CH, Kim DW, Dong IK, Lee TK and Lee CH: Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2. Am J Chin Med. 30:95–108. 2002. View Article : Google Scholar : PubMed/NCBI
27	Choi EM and Lee YS: Effects of hesperetin on the production of inflammatory mediators in IL-1beta treated human synovial cells. Cell Immunol. 264:1–3. 2010. View Article : Google Scholar : PubMed/NCBI
28	Dong M, Hu N, Hua Y, Xu X, Kandadi MR, Guo R, Jiang S, Nair S, Hu D and Ren J: Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta. 1832:848–863. 2013.PubMed/NCBI
29	Wang XL, Wang X, Xiong LL, Zhu Y, Chen HL, Chen JX, Wang XX, Li RL, Guo ZY, Li P and Jiang W: Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis: doxorubicin cardiotoxicity inhibited by salidroside. J Cardiovasc Pharmacol. 62:512–523. 2013. View Article : Google Scholar
30	Mairuae N, Hall Ii EC, Cheepsunthorn P, Lee SY and Connor JR: The H63D HFE gene variant promotes activation of the intrinsic apoptotic pathway via mitochondria dysfunction following β-amyloid peptide exposure. J Neurosci Res. 88:3079–3089. 2010.PubMed/NCBI
31	Chai WS, Zhu XM, Li SH, Fan JX and Chen BY: Role of Bcl-2 family members in caspase-3/9-dependent apoptosis during Pseudomonas aeruginosa infection in U937 cells. Apoptosis. 13:833–843. 2008. View Article : Google Scholar : PubMed/NCBI
32	Chen M, Guerrero AD, Huang L, Shabier Z, Pan M, Tan TH and Wang J: Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem. 282:33888–33895. 2007. View Article : Google Scholar : PubMed/NCBI
33	Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA and De Franco MF: The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Rep. 3:261–267. 2010. View Article : Google Scholar
34	Zhai CL, Zhang MQ, Zhang Y, Xu HX, Wang JM, An GP, Wang YY and Li L: Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol Sin. 33:1477–1487. 2012. View Article : Google Scholar : PubMed/NCBI